Role of peroxisome proliferator-activated receptor α in altered cell cycle regulation in mouse liver

Role of peroxisome proliferator-activated receptor α in altered cell cycle regulation in mouse liver
复制标题

DOI:
10.1093/carcin/19.11.1989
复制
发表时间:
1998-11-01
期刊:
影响因子:
4.7
通讯作者:
Gonzalez, FJ
Gonzalez, FJ
中科院分区:
医学2区
文献类型:
--
作者:
Peters, JM;Aoyama, T;Gonzalez, FJ

文献摘要

被引文献

相似文献

过氧化物酶体增殖物诱导的肝癌发生的潜在机制尚不清楚,但由过氧化物酶体增殖物激活受体α(PPARalpha)介导。为了确定PPARalpha在肝癌发生机制中的作用,评价了Wy-14,643对酰基CoA氧化酶(ACO)和PPARalpha缺失小鼠中参与细胞增殖的蛋白质的表达模式的影响。与对照组相比,野生型小鼠喂食Wy-14,643 5周或11个月后,AGO、CDK-1、CDK-2、CDK-4、PCNA和c-myc蛋白均显著增加。在Wy-14,643处理的PPARa缺失小鼠中未观察到该效应。细胞周期蛋白B1,细胞周期蛋白D,细胞周期蛋白E和p53的表达模式在任何组中没有差异。编码CDK-1、CDK-4、细胞周期蛋白D1和c-myc的mRNA在喂食Wy-14,643的野生型小鼠中也增加,但在PPARa缺失小鼠中没有增加。这些结果表明,CDK-1,CDK-4和c-myc的增加可能是由PPAR α直接或间接介导的转录增加引起的。因此,过氧化物酶体增殖物诱导的细胞周期调节蛋白的PPAR α依赖性改变可能有助于过氧化物酶体增殖物的肝癌性。
The mechanisms underlying peroxisome proliferator-induced hepatocarcinogenesis are unclear but are mediated by the peroxisome proliferator-activated receptor a (PPAR alpha), To determine the role of PPAR alpha in the mechanisms of hepatocarcinogenesis, the effect of Wy-14,643 on expression patterns of acyl CoA oxidase (ACO) and proteins involved in cell proliferation in the PPAR alpha-null mouse were evaluated. AGO, CDK-1, CDK-2, CDK-4, PCNA and c-myc proteins were significantly increased in wild-type mice fed Wy-14,643 for 5 weeks or 11 months, as compared with controls. This effect was not observed in Wy-14,643-treated PPARa-null mice. Expression patterns of cyclin B1, cyclin D, cyclin E and p53 were not different in any of the groups. mRNAs encoding CDK-1, CDK-4, cyclin D1 and c-myc were also increased in wild-type mice fed Wy-14,643 but not in PPARa-null mice. These results indicate that the increase in CDK-1, CDK-4 and c-myc may be caused by an increase in transcription that is mediated directly or indirectly by PPAR alpha. Thus PPAR alpha-dependent alterations in cell cycle regulatory proteins induced by peroxisome proliferators are likely to contribute to the hepatocarcinogenicity of peroxisome proliferators.